focus -WSS

focus

author：comprehensive 2025-09-27 10:03:49 - browse：55

In 2018, New York University became the first U.S. medical school to go tuition free. Since then, a handful of others have followed with many more considering similar programs. One hope for free tuition endeavors is that lower post-graduation debt will increase the number of med students who choose lower-paying, desperately needed careers in primary care and pediatrics. But free tuition programs are not necessarily delivering on that promise.

In this episode of the First Opinion Podcast, University of Pennsylvania oncologist and researcher Ezekiel Emanuel and Matthew Guido, a project manager in the Healthcare Transformation Institute, discuss their original research on tuition-free programs with former host Pat Skerrett, who is filling in while Torie Bosch is on maternity leave. They make the case that medical school debt is only one of many factors that influence new doctors to choose less-popular specialties and geographic locations for their residencies. Other factors including prestige, the lifetime earning potential of higher-pay specialties, which can add several millions dollars over a career, can have more sway than student debt alone. This is especially important, they say, as needs for patients with chronic illnesses are rapidly outpacing the number of primary care physicians available to give that care.

“We have undervalued both philosophically and also financially the complications of managing chronic illness,” Emanuel says. “Can we rebalance the payment system that rewards the improvements in health and therefore the attention to chronic illness through primary care?”

You can read more about Emanuel and Guido’s opinions in their essay “Free med school tuition won’t solve the shortage of primary care physicians.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Alkermes shareholders re
Next article： Novo Nordisk obesity pill bests Wegovy in early trial

WSS

Just how do doctors, lawmakers, and the public define abortion?

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

5 important ways Henrietta Lacks changed medical science

Mega Millions pot grows to $1.25 billion after no winner

The high personal cost of affirmative action for Black doctors

NEJM study link tiny plastics in blood vessels to heart problems

Wikipedia

focus

hotspot

What does generative AI mean for health care? We asked experts

Amylyx ALS drug failure raises questions and concerns

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Amylyx ALS drug failure raises questions and concerns

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Physician groups backed by private equity giant lobby on mergers

Peter Hotez and the public health issue of online harassment

Trump indictment: Who are the 'co

knowledge

Headspace, Meta partner to launch VR meditation app for Quest

Change Healthcare cyberattack prompts Medicare loan program

Vertex non

How to bring more disabled researchers into academia

NEJM study link tiny plastics in blood vessels to heart problems

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

knowledge

explore

leisure time

entertainment